CEL-SCI Corp (CVM) Stock Analysis

CEL-SCI Corp (CVM) is a publicly traded company in the HEALTHCARE sector. It trades at $1.48, carries a market capitalization of $21.45M. This page summarizes the public market data, fundamentals, and frequently asked questions for CVM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $1.48
• Market Cap: $21.45M
• EPS: $-2.15
• 52-Week High: $13.48
• 52-Week Low: $0.89

Market Sentiment

CEL-SCI Corp currently has a Bullish sentiment score of 0.26.

About CEL-SCI Corp

CEL-SCI Corporation (CVM) is an innovative biotechnology company focused on advancing immunotherapy solutions for cancer and infectious diseases. Based in Vienna, Virginia, the company is dedicated to developing its lead product candidate, Multikine, which aims to harness the body's immune system to target and destroy tumors. With a robust pipeline and commitment to addressing unmet medical needs, CEL-SCI is positioned to make significant contributions to the field of cancer treatment and bey...

GNG Research Analysis

GNG Research scores CEL-SCI Corp (CVM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CVM.

Frequently Asked Questions

Does CVM pay dividends?

CEL-SCI Corp (CVM) does not currently pay a regular dividend.

What is CVM's market cap?

CEL-SCI Corp (CVM) has a market capitalization of $21.45M with a current stock price of $1.48.